docetaxel,darolutamide
bayer
['nubeqa', 'prostate', 'arasens', 'gu ', 'darolutamide', '$bayry']
$bayry new nubeqa (darolutamide) subgroup analyses from the phase iii arasens trial in metastatic hormone-sensitive prostate cancer (mhspc) patients presented at asco gu - 
News and analysis of biomedical, biopharma, biotech, biosciences, pharmaceutical, and technology equities